Articles

ST.26 Feature Keys: Complete Reference for Biological Patents

If you are involved in filing biological patents, understanding ST.26 feature keys is absolutely essential. The World Intellectual Property Organization (WIPO) introduced the ST.26 standard to replace the older ST.25 format, bringing a modernized and globally unified approach to sequence listings in patent applications. At the heart of this standard lies a powerful concept called “feature keys,” which are structured annotations used to describe the biological characteristics of nucleotide and amino acid sequences. This complete reference guide will walk you through everything you need to know about ST.26 feature keys in a simple, easy-to-understand manner, helping patent professionals, bioinformaticians, and researchers navigate this critical requirement with confidence.

What Are ST.26 Feature Keys?

ST.26 feature keys are standardized labels or identifiers used within a sequence listing to describe specific biological features of a given sequence. Think of them as tags or annotations that tell a patent examiner exactly what a particular region of a DNA, RNA, or protein sequence does, where it starts, where it ends, and what its biological significance is.

Every sequence submitted under the ST.26 standard must follow the feature key vocabulary defined by the International Nucleotide Sequence Database Collaboration (INSDC). This vocabulary ensures that every patent office around the world interprets sequence annotations in the same way, removing ambiguity and improving the quality of biological patent examination.

The feature annotation in ST.26 consists of three main components. The first is the feature key itself, which is the name of the biological feature such as “gene,” “CDS,” or “misc_feature.” The second is the location, which defines the exact position of the feature on the sequence using coordinates. The third is the qualifier, which provides additional detail about the feature, such as the name of the gene or the product it encodes.

Types of ST.26 Feature Keys You Must Know

ST.26 feature keys are borrowed directly from the INSDC Feature Table, which is maintained jointly by GenBank, EMBL-Bank, and DDBJ. These keys are divided into categories based on the type of sequence they annotate.

Feature Keys for Nucleotide Sequences

When dealing with DNA or RNA sequences in biological patents, the following st.26 feature keys are most commonly used:

  • gene: Marks a region of the sequence that corresponds to a known gene. It is often used alongside the /gene qualifier to name the gene.
  • CDS (Coding Sequence): One of the most important st.26 feature keys, CDS identifies the portion of a nucleotide sequence that encodes a protein. It must always be accompanied by a /translation qualifier showing the amino acid sequence.
  • mRNA: Indicates the messenger RNA representation of a gene, including untranslated regions.
  • exon: Defines the region of a gene that is represented in the final mature RNA product.
  • intron: Marks the non-coding intervening sequence between exons.
  • promoter: Identifies the regulatory region upstream of a gene where transcription begins.
  • 5’UTR and 3’UTR: These keys annotate the untranslated regions at the beginning and end of an mRNA sequence respectively.
  • misc_feature: Used when no other key accurately describes the feature. It is flexible but should always be accompanied by a /note qualifier explaining its purpose.
  • variation: Used to describe a point mutation, polymorphism, or other sequence variation.

Feature Keys for Amino Acid Sequences

For protein sequences submitted under st.26 feature keys, the vocabulary is more specialized:

  • Region: Describes a specific domain or structural region of a protein.
  • Site: Marks a biologically active site such as an active site, binding site, or cleavage site.
  • Bond: Indicates a cross-link or disulfide bond between two residues.
  • mat_peptide: Identifies the mature peptide produced after post-translational cleavage of a signal peptide or propeptide.
  • sig_peptide: Marks the signal peptide, which is the portion of the protein that directs its secretion or membrane insertion.
  • misc_feature: Similar to its use in nucleotide sequences, this key serves as a catch-all for protein features that do not fit neatly into any other category.

How to Apply ST.26 Feature Keys Correctly in Patent Filings?

Understanding the theory behind st.26 feature keys is only half the job. Applying them correctly in a patent application requires precision, consistency, and familiarity with the rules laid out in the ST.26 standard document published by WIPO.

Location Descriptors Matter: Each feature key must be given an accurate location on the sequence. A simple feature may span a single continuous range, while complex features may use operators like “join()” to combine multiple discontinuous regions or “complement()” to indicate that the feature is on the opposite strand of a double-stranded nucleotide sequence.

Mandatory Qualifiers Must Be Included: Certain st.26 feature keys require specific qualifiers. For example, every CDS entry must include a /translation qualifier containing the corresponding protein sequence. Missing this qualifier is one of the most common errors found during patent examination.

Use of the /mol_type Qualifier: Every source feature, which is a mandatory feature in all ST.26 sequence listings, must include the /mol_type qualifier. This specifies the type of molecule being described, such as genomic DNA, mRNA, or protein.

Avoid Overlapping Features Without Justification: While overlapping feature annotations are permitted under st.26 feature keys, they should be used only when biologically justified. Excessive or unexplained overlaps can raise questions during examination.

Consistency With Claims: The features annotated using st.26 feature keys in the sequence listing should be consistent with the claims made in the patent application. A feature annotated as a “promoter” in the listing should be described as such in the claims and the detailed description.

Why ST.26 Feature Keys Are Critical for Patent Quality?

The introduction of st.26 feature keys as a standardized system has significantly improved the quality and interoperability of biological patent data across international jurisdictions. Patent offices including the USPTO, EPO, JPO, and CNIPA all now require ST.26-compliant sequence listings, making it a truly global requirement.

For applicants, proper use of st.26 feature keys reduces the risk of receiving formal objections from patent offices, speeds up the examination process, and ensures that the scope of protection being claimed is clearly communicated through structured biological data. For examiners, these feature keys provide an organized and searchable framework for comparing sequences against prior art.

Incorrect or missing feature annotations can lead to compliance rejections, requests for sequence listing corrections, or even loss of filing date in some jurisdictions. Given the high stakes involved in biological patent prosecution, mastering st.26 feature keys is not optional. It is a fundamental competency for anyone working at the intersection of biology and intellectual property.

Final Thoughts

ST.26 feature keys form the backbone of accurate and compliant sequence listings in biological patents. From defining coding sequences and protein domains to marking regulatory elements and binding sites, these keys give structured meaning to raw sequence data. By following the INSDC feature table vocabulary, using qualifiers correctly, and ensuring alignment with patent claims, applicants can produce high-quality sequence listings that meet international standards. Whether you are a patent attorney, a scientific advisor, or a bioinformatics specialist, building a solid understanding of st.26 feature keys will directly improve the quality and enforceability of the biological patents you work on.

We are the leading Patent Sequence Listing Company

At our Sequence Listing Company, we specialize exclusively in creating perfect patent sequence listings for biotechnology and pharmaceutical companies. Founded by patent attorneys and bioinformatics specialists with over 10 years of experience, we understand the critical intersection of scientific innovation and intellectual property protection. Our dedicated team has helped hundreds of companies successfully navigate the complex regulatory requirements of sequence listings across global patent offices. We combine technical precision with regulatory expertise to ensure your valuable innovations receive the protection they deserve without delays or complications.

Our Expertise

Trust Your Patent Sequence Listings to the Industry's Leading Experts

Powered by

Effectual Services is an award-winning Intellectual Property (IP) management advisory & Consulting firm.

Office
@2026 The Sequence Listing. All rights reserved.